title: The ferric iron chelator 2,2'-dipyridyl attenuates basilar artery vasospasm and improves neurological function after subarachnoid hemorrhage in rabbits.
abstract: We investigated the efficacy of the ferrous iron (Fe(2+)) chelator 2,2'-dipyridyl (DP) to attenuate cerebral vasospasm after subarachnoid hemorrhage (SAH). Thirty-six New Zealand white rabbits were randomly assigned to four groups: untreated control, SAH, SAH + dimethyl sulfoxide (DMSO) vehicle, and SAH + DP. SAH was induced by injection of autologous blood into the cisterna magna and then DP or vehicle was infused into the cistern magna for 5 days (20 mg/kg/day or an equal volume of DMSO). Neurological deficit score (NDS) was used to assess neurological function and cerebral angiography to measure basilar artery (BA) diameter following SAH. TUNEL staining was used to detect BA endothelial cell apoptosis, and immunohistochemistry and Western blotting to assess changes in caspase-3 protein levels 5 days post-SAH. The SAH + DP group had a significantly larger mean BA diameter and lower mean NDS post-SAH compared to the SAH + DMSO and SAH groups (p < 0.05). TUNEL-positive cell numbers and caspase-3 levels were significantly reduced in BA endothelial cells of the SAH + DP group as compared to the SAH and SAH + DMSO groups (p < 0.05). The iron chelator DP reduced vasospasm and neurological sequelae in rabbits, likely by chelating the Fe(2+) in oxyhemoglobin and reducing oxidative stress-induced endothelial cell apoptosis.
authors.affiliation: Department of Neurosurgery, The Affiliated Hospital, The Logistics College of Chinese People's Armed Police Forces, Tianjin, 300162, People's Republic of China, yuyaoyumedsci@163.com.
authors.forename: Yaoyu
authors.initials: Y
authors.lastname: Yu
authors.forename: Zhichun
authors.initials: Z
authors.lastname: Lin
authors.forename: Yiheng
authors.initials: Y
authors.lastname: Yin
authors.forename: Jianwu
authors.initials: J
authors.lastname: Zhao
mesh_terms: D015082:2,2'-Dipyridyl / Q000627:therapeutic use*; D015901:Angiography, Digital Subtraction; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001488:Basilar Artery / Q000187:drug effects / Q000473:pathology; D001804:Blood Transfusion, Autologous / Q000009:adverse effects; D053148:Caspase 3 / Q000378:metabolism; D002533:Cerebral Angiography; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000187:drug effects; D005260:Female; D020287:In Situ Nick-End Labeling; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008297:Male; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology; D009460:Neurologic Examination; D011817:Rabbits; D013345:Subarachnoid Hemorrhage / Q000150:complications*; D020301:Vasospasm, Intracranial / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D007502:Iron Chelating Agents; D015082:2,2'-Dipyridyl; D053148:Caspase 3
references.citation: Stroke. 1991 May;22(5):666-73
references.pmid: 2028499
references.citation: J Neurosurg. 1998 Mar;88(3):557-61
references.pmid: 9488312
references.citation: Lancet. 2007 Jan 27;369(9558):306-18
references.pmid: 17258671
references.citation: Acta Neurochir Suppl. 2008;104:33-41
references.pmid: 18456995
references.citation: Free Radic Biol Med. 2005 Apr 15;38(8):1057-72
references.pmid: 15780764
references.citation: Neurol Res. 1999 Sep;21(6):553-8
references.pmid: 10491814
references.citation: Rev Recent Clin Trials. 2007 Jan;2(1):59-67
references.pmid: 18473989
references.citation: Surg Neurol. 1989 Dec;32(6):408-17
references.pmid: 2636794
references.citation: J Cereb Blood Flow Metab. 2004 Apr;24(4):419-31
references.pmid: 15087711
references.citation: Neurol Res. 1980;2(3-4):253-72
references.pmid: 6111034
references.citation: J Neurosurg. 1992 Nov;77(5):763-7
references.pmid: 1403120
references.citation: Stroke. 2004 Oct;35(10):2412-7
references.pmid: 15322302
references.citation: Brain. 2001 Feb;124(Pt 2):249-78
references.pmid: 11157554
references.citation: Br J Haematol. 1995 Jan;89(1):181-7
references.pmid: 7833261
references.citation: Brain Res. 2008 Feb 8;1193:136-42
references.pmid: 18177633
references.citation: J Toxicol Environ Health. 1982 Sep;10(3):363-72
references.pmid: 7175967
references.citation: Circulation. 1997 Nov 18;96(10):3602-9
references.pmid: 9396461
references.citation: Brain Res. 2001 Jan 19;889(1-2):89-97
references.pmid: 11166691
references.citation: Neurosci Lett. 2002 Jun 28;326(2):137-41
references.pmid: 12057847
references.citation: Stroke. 2005 Aug;36(8):1627-32
references.pmid: 16049199
references.citation: Neurosurgery. 2005 Apr;56(4):633-54; discussion 633-54
references.pmid: 15792502
references.citation: J Pharm Pharmacol. 2007 Nov;59(11):1549-53
references.pmid: 17976267
references.citation: Crit Rev Toxicol. 2004 Sep-Oct;34(5):447-60
references.pmid: 15560568
references.citation: Mol Med Today. 1997 Jun;3(6):232
references.pmid: 9211408
references.citation: J Neurosurg Sci. 2007 Mar;51(1):1-9
references.pmid: 17369785
references.citation: Eur J Neurosci. 2005 Sep;22(5):1045-56
references.pmid: 16176346
references.citation: Stroke. 2001 Jan;32(1):154-61
references.pmid: 11136931
references.citation: Jpn J Ophthalmol. 2005 Sep-Oct;49(5):355-62
references.pmid: 16187034
references.citation: Neurosurgery. 1997 Dec;41(6):1385-91; discussion 1391-2
references.pmid: 9402590
references.citation: J Neurosurg. 1998 Feb;88(2):298-303
references.pmid: 9452239
references.citation: J Biol Chem. 2002 Jul 12;277(28):25568-75
references.pmid: 11980894
references.citation: Life Sci. 2002 May 10;70(25):3007-18
references.pmid: 12138014
references.citation: Cell Immunol. 2002 Dec;220(2):96-106
references.pmid: 12657244
references.citation: Cancer Res. 2009 Mar 15;69(6):2365-74
references.pmid: 19258503
references.citation: Neurochem Int. 2008 May;52(6):1044-51
references.pmid: 18082289
references.citation: Stroke. 1991 Aug;22(8):971-82
references.pmid: 1866764
references.citation: Acta Neurochir Suppl. 2008;105:3-6
references.pmid: 19066072
references.citation: J Neurochem. 2001 May;77(4):1128-35
references.pmid: 11359878
references.citation: Crit Rev Neurosurg. 1999 Sep 24;9(5):303-318
references.pmid: 10525849